Disease Spotlight: Prostate Cancer

Latest News

Adjunctive AI Bolsters Lesion-Level PPVs for csPCa in International bpMRI Study
Adjunctive AI Bolsters Lesion-Level PPVs for csPCa in International bpMRI Study

July 17th 2025

The use of adjunctive bpMRI-based AI led to 10 percent and greater increases in lesion-level PPV for csPCa and PCa with a threshold of PI-RADS > 3.

Study: Adjunctive AI Provides Over 18 Percent Higher Lesion-Level Sensitivity on Prostate MRI
Study: Adjunctive AI Provides Over 18 Percent Higher Lesion-Level Sensitivity on Prostate MRI

July 15th 2025

Emerging Medication for mCRPC Gets FDA Fast Track Designation for Adjunctive Use with Radiation Therapy
Emerging Medication for mCRPC Gets FDA Fast Track Designation for Adjunctive Use with Radiation Therapy

July 10th 2025

CMS Issues Permanent HCPCS Code for the PSMA PET Prep Modality Gozellix
CMS Issues Permanent HCPCS Code for the PSMA PET Prep Modality Gozellix

July 9th 2025

FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy
FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy

June 24th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.